15
total announcements
524396.BO · 15 min delayed
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced the closure of its trading window from October 1, 2026, due to the consideration of un-audited financial results for the quarter ended September 30, 2026.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director, despite attaining the age of 75 years, as per the 41st Annual General Meeting held on September 23, 2026.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced the voting results and scrutinizer's report for its 41st Annual General Meeting (AGM) held on September 23, 2026. The meeting was conducted through video conference and e-voting, and all resolutions were approved by the shareholders with the requisite majority.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd held its 41st Annual General Meeting (AGM) on September 23, 2026, through video conference. The meeting was attended by 42 members, and the requisite quorum was present. The company secretary briefed the members on the participation through VC/OAVM and informed them about the remote e-voting process. The chairman delivered his opening remarks on the company's performance and future positioning. The meeting transacted two items of business, including the adoption of audited financial statements and the appointment of a director.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced the notice of its 41st Annual General Meeting to be held on September 23, 2026, through video conferencing. The company has also provided remote E-voting facilities to its members.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced information regarding e-voting for its 41st Annual General Meeting scheduled on September 23, 2026, through video conferencing.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has sent a letter to shareholders whose email addresses are not registered with the company, registrar, or depository participants, informing them that the Annual Report and Notice of 41st AGM are available on the company's website.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has submitted its Integrated Annual Report for the financial year 2025-26 along with the notice convening the 41st Annual General Meeting.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has submitted a notice for its 41st Annual General Meeting (AGM) scheduled to be held on September 23, 2026, through video conferencing. The meeting will consider the audited financial statements for the year ended March 31, 2026, and re-appoint Mr. Smitesh Shah as a director. The company will also consider a special resolution to continue the directorship of Mr. Ashok Kumar Ramawat beyond his 75th birthday.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has published a notice of its 41st Annual General Meeting (AGM) through video conferencing or other audio-visual means, as per the regulations.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 281.85 lakhs and a total income from operations of Rs. 1,178.50 lakhs.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced the continuation of Mr. Ashok Kumar Ramawat as a Non-executive Independent Director of the company, despite him attaining the age of 75. The decision was approved by the Board of Directors and is subject to shareholder approval at the upcoming 41st Annual General Meeting.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd announced its un-audited financial results for the quarter ended 30th June 2026, with the Board of Directors approving the results and recommending the continuation of directorship of Mr. Ashok Kumar Ramawat. The company also convened its 41st Annual General Meeting on 23rd September 2026.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director, convening the 41st Annual General Meeting on September 23, 2026, and submitting the required disclosures as per SEBI regulations.
Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 to consider and approve the Un-Audited Financial Results for the first Quarter ended on 30th June, 2026.